Growth Metrics

Arcturus Therapeutics Holdings (ARCT) Receivables - Other: 2018-2025

Historic Receivables - Other for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Sep 2025 value amounting to $8.0 million.

  • Arcturus Therapeutics Holdings' Receivables - Other fell 73.67% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 73.67%. This contributed to the annual value of $4.0 million for FY2024, which is 87.61% down from last year.
  • Arcturus Therapeutics Holdings' Receivables - Other amounted to $8.0 million in Q3 2025, which was down 53.78% from $17.2 million recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Receivables - Other ranged from a high of $92.5 million in Q1 2023 and a low of $2.0 million during Q1 2021.
  • In the last 3 years, Arcturus Therapeutics Holdings' Receivables - Other had a median value of $24.1 million in 2024 and averaged $26.4 million.
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Receivables - Other skyrocketed by 2,405.64% in 2023 and then slumped by 87.61% in 2024.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Receivables - Other (Quarterly) stood at $3.4 million in 2021, then decreased by 17.91% to $2.8 million in 2022, then surged by 1,060.06% to $32.1 million in 2023, then crashed by 87.61% to $4.0 million in 2024, then plummeted by 73.67% to $8.0 million in 2025.
  • Its Receivables - Other stands at $8.0 million for Q3 2025, versus $17.2 million for Q2 2025 and $14.6 million for Q1 2025.